Search results for: Innovation

Competition through Innovation, Innovation through Competition

1 November 1998

…henceforth referred to as ‘incremental innovations’ to distinguish them from ‘breakthrough innovations’. According to such criticisms, the prevalence of a ‘me-too’ R&D strategy would have three serious negative implications: 1….

Plan For A New EU Pharmaceutical Legislation: What Will It Mean For Pharmaceutical Innovation?

12 April 2024

…and the development of pharmaceutical innovation. Consequently, factors and incentive systems that can reduce the pharmaceutical market size may negatively affect the R&D of pharmaceutical innovation. A report by Copenhagen…

How Does Pharmaceutical Spending Drive Innovation in Europe?

7 February 2022

…the relationship between pharmaceutical revenue and innovation by looking at the elasticity of early-stage innovation in Europe. An ‘elasticity’ measures the relationship between two factors, i.e., how much y responds…

Innovation for Health System Efficiency and Improvement

20 November 2023

…(e.g. technology barriers) 2) the health system’s ability to fund or integrate the innovation, and 3) the clinicians’ and patients’ readiness and willingness to engage with the innovation. Overcoming barriers…

Estimating the Impact of U.S. Drug Price-setting Policies on Innovation Is Challenging, Even for the Congressional Budget Office

22 June 2022

…the future of innovation. To aid policymakers in understanding the potential impacts of drug pricing policy on future innovation, the Congressional Budget Office (CBO) has developed a model that simulates…

CBO Doesn’t Capture The Real Impact of H.R. 3 on Innovation 

14 September 2021

…volume of innovation that is important, but the value of that innovation. In health care innovation should generate “value” by (1) improving patients’ quality and/or or length of life and/or…

Spotlight on OHE: Innovation, Regulation and Antibiotics

30 September 2014

…analysing the nature of innovation and the effects of regulation. Two recent OHE presentations address the core issues. Incentives for innovation in antibiotics The growing crisis of antibiotic resistance and…

OHE Lunchtime Seminar: The People’s Prescription – Re-imagining Health Innovation to Deliver Public Value

7 September 2018

…health innovation to deliver public value’. To be held on 28th September 2018 from 12 p.m. to 2 p.m. Health innovation would be futile and unjust if it did not…

Economics of Innovation

…to medical innovation?   What role does market competition play in promoting investment in R&D and maximising access to medical innovation? Key objective for this research theme: Promoting innovation in health…